Arrow Down

GripAble joins ABHI US Accelerator 2022 cohort

GripAble is delighted to be joining the Association of British HealthTech Industries (ABHI) US Accelerator 2022 cohort. Now in its fifth year, the ABHI US Accelerator, conducted in partnership with the Dell Medical School in Austin, Texas, supports UK medical device, diagnostic and digital health companies looking to access the US healthcare landscape. The 12-month programme provides companies with the opportunity to define and strengthen their US strategy, de-risk market entry and grow their US business by utilising ABHI’s advice, expertise and connections within the country.

Over the next 12 months, ABHI will work with GripAble along with 39 other companies who have been successful on this year’s programme, providing them with bespoke support in identifying and filling need gaps, and setting individual goals to support their growth. Companies will also be boosted by access to an expansive network of in-market experts.

The 2022 ABHI US Accelerator programme will run from January 2022 – December 2022, with participants able to make full use of ABHI’s dedicated workspace and office at the Dell Medical School, with access to their facilities and support from senior faculty.

Since its establishment in 2017, the ABHI US Accelerator has led to over 25 international research collaborations and new business generated for UK industry. The programme has been expanded over the years, and is now supporting 40 companies, several of which are long- standing members of the programme, drive their operations in the US. Centred in Texas, and using the state as a springboard to other key states, the programme offers nationwide support, drawing on the relationships and connections built up across the US.

Danielle Richards, GripAble Commercial Manager, said:

“The ABHI US Accelerator provides us with a valuable ecosystem of clinicians, investors and mentors to help us develop our presence in the all-important US market.”

Paul Benton, ABHI Managing Director, International, said:

“We are delighted that our programme continues to attract such high caliber applicants. The ABHI US Accelerator is a fantastic platform for UK HealthTech innovators looking to access the US healthcare landscape. In helping companies to de-risk US market entry, it also acts as a catalyst for growth, offering access to senior physicians, c-suite level health system executives, payers and a broad network of US healthcare contacts. We look forward to supporting each company in their goal to grow and develop within one of the world’s largest HealthTech markets.”

About GripAble

GripAble is an award-winning technology company developing an end-to-end digital platform for assessment and gamified rehabilitation for people with physical and cognitive disabilities. The company has been developing its solution over the last eight years in consultation with thousands of occupational and physical therapists and patients across multiple clinical conditions and leading academic institutions, including Imperial College London. GripAble launched its mobile app along with its first hand-held sensor in 2020, focusing on supporting those undergoing upper limb rehabilitation

About ABHI

ABHI is the UK’s leading industry association for health technology (HealthTech). ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators.

HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is now the largest employer in the broader Life Sciences sector, employing 138,100 people in 4,140 companies, with a combined turnover of £27.6bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 320 members account for approximately 80% of the sector by value.

For more information about the ABHI US Accelerator please click here